In a model of bronchopulmonary dysplasia (BPD), neonatal rats were treated with recombinant CCN1 protein, and it reduced hyperoxia‐induced lung injury, indicating that CCN1 has an anti‐inflammatory effect.30 The gene discussed is CCN1; the disease is bronchopulmonary dysplasia.